Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study

 

First European Performance-Focused Skechers Store Opens in Belgium

 

CTP N.V. Q1-2025 Results

 

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

 

QIAGEN announces plans for transition in leadership of Supervisory Board

 

Miro Launches Solution Partner Program to Accelerate Enterprise Innovation and Collaboration

 

Nebius Welcomes Bezos Expeditions as Lead Investor in AI Data Business Toloka

 

Crown Bioscience Achieves Green Lab Sustainability Certification

 

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

 

VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston